New Zealand markets closed

Aridis Pharmaceuticals, Inc. (ARDS)

OTC Markets EXMKT - OTC Markets EXMKT Delayed price. Currency in USD
Add to watchlist
0.00100.0000 (0.00%)
As of 04:00PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
19,602
0
0
0
0
Operating expenses
Research development
17,381
25,923
36,936
16,956
24,083
Selling general and administrative
5,861
7,161
7,310
6,445
6,026
Total operating expenses
20,485
29,993
42,711
22,401
29,087
Operating income or loss
-883
-29,993
-42,711
-22,401
-29,087
Total other income/expenses net
-436
-257
763
-9
-951
Income before tax
-1,142
-30,371
-42,193
-22,333
-29,681
Income from continuing operations
-1,142
-30,371
-42,193
-22,333
-29,681
Net income
-1,142
-30,371
-42,193
-22,333
-29,681
Net income available to common shareholders
-1,142
-30,371
-46,320
-22,333
-29,681
Basic EPS
-0.12
-1.62
-3.85
-2.44
-3.51
Diluted EPS
-0.16
-1.62
-3.85
-2.44
-3.51
Basic average shares
32,173
18,777
12,292
9,169
8,458
Diluted average shares
40,885
18,777
12,292
9,169
8,458